Flagship @ JPM 2025
Watch discussions from the Flagship Studio at the 2025 J.P. Morgan Healthcare Conference in San Francisco.
Highlights from the Flagship Studio @ JPM 2025
Watch programming from our studio at the 2025 J.P. Morgan Healthcare Conference.
Latest from the Flagship Studio

Lessons in Leadership: Angela Hwang in Conversation with Joy Right

Pioneering Partnerships: Accelerating our Collaboration with Pfizer

Pioneering Partnerships: Spurring Biotech Innovation in Singapore and Beyond

2025 CEO Chat: Steve Harr, CEO of Sana Biotechnology

Pioneering Partnerships: Developing Next Generation Therapeutics for Obesity Management

2025 CEO Chat: Michelle Werner, CEO of Alltrna
CEO Chats

2025 CEO Chat: Adrian Gottschalk, CEO of Foghorn Therapeutics

2025 CEO Chat: Steve Hahn, CEO of Harbinger Health

2025 CEO Chat: Angela Hwang, CEO of Metaphore Biotechnologies

2025 CEO Chat: Eric Shaff, CEO of Seres Therapeutics

2025 CEO Chat: Craig Williams, CEO of Apriori Bio

2025 CEO Chat: Margo Georgiadis, Co-founder & CEO of Montai
CEO Chats

2025 CEO Chat: Stéphane Bancel, CEO of Moderna

2025 Company Chat: Jens Vogel, President & Chief Operating Officer of Mirai Bio

2025 CEO Chat: John Lepore, CEO of ProFound Therapeutics

2025 CEO Chat: Lovisa Afzelius, Co-founder & Founding CEO of Prologue Medicines

2025 CEO Chat: Jason Gardner, CEO of Ampersand Biomedicines

2025 CEO Chat: Torben Straight Nissen, CEO of Repertoire Immune Medicines
CEO Chats

2025 CEO Chat: Mike Nally, CEO of Generate Biomedicines

2025 CEO Chat: Brian Alexander, CEO of Valo Health

2025 CEO Chat: Mike Severino, CEO of Tessera Therapeutics

2025 CEO Chat: Jason Park, CEO of Empress Therapeutics

2025 CEO Chat: Jake Rubens, CEO of Quotient Therapeutics

2025 CEO Chat: Guillaume Pfefer, CEO of Sail Biomedicines
